Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cells. | Synapse
March 8, 2026
Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cells.
Puntos clave
This research aims to evaluate the effects of PAK inhibition combined with PD-1 blockade on ovarian cancer treatment.
Evaluated the efficacy of PAK inhibition alongside PD-1 blockade
Focused on high-grade serous ovarian cancer models
Assessed cytotoxic CD8+ T cell activation and cancer cell invasion
PAK inhibition significantly enhanced CD8+ T cell-mediated killing of ovarian cancer cells
The combination therapy suppressed cancer cell invasion
Efficacy was observed in vitro, indicating potential for improved patient outcomes
Resumen
The work presented here demonstrates the efficacy of PAK inhibition and PD-1 checkpoint blockade as a combination therapy for high-grade serous ovarian cancer.